SCHEMBL6018931

SCHEMBL6018931

COC(=O)C1CCC(OCCCCOCc2ccccc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
EPHX2 P34913 2/20 0.46
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
BCHE P06276 3/20 0.41
NAAA Q02083 1/20 0.41
GAA P10253 1/20 0.40
CPB1 P15086 1/20 0.40
LTA4H P09960 1/20 0.40
TEAD3 Q99594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6019299 1.00 ALDH1A1 (0.46) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL6018928 1.00 ALDH1A1 (0.46) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL6018885 0.87 ALDH1A1 (0.50) ALDH1A1EPHX2NPC1RAB9AL3MBTL1
SCHEMBL6018878 0.87 ALDH1A1 (0.50) ALDH1A1EPHX2NPC1RAB9AL3MBTL1
SCHEMBL20501772 0.86 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL13470194 0.86 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL15511981 0.86 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL6019021 0.86 LTA4H (0.46) ALDH1A1EPHX2NPC1RAB9ADRD2
SCHEMBL6019016 0.86 LTA4H (0.46) ALDH1A1EPHX2NPC1RAB9ADRD2
SCHEMBL3094987 0.83 TSHR (0.50) EPHX2L3MBTL1TDP1BCHELTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100503560-C Substituted cyclohexane derivatives HOFFMANN LA ROCHE (CH) 2009-06-24 CN disclosed
EP-1456171-B1 SUBSTITUTED CYCLOHEXANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-12-20 EP disclosed
US-20050272774-A1 Substituted cyclohexane derivatives ACKERMANN JEAN 2005-12-08 US disclosed
US-6953806-B2 Substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. (US) 2005-10-11 US disclosed
CN-1604890-A Substituted cyclohexane derivatives HOFFMANN LA ROCHE (CH) 2005-04-06 CN disclosed
EP-1456171-A1 SUBSTITUTED CYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-09-15 EP disclosed
US-20030199550-A1 Substituted cyclohexane derivatives F.HOFFMANN-LA ROCHE AG (CH) 2003-10-23 US disclosed
WO-2003053919-A1 SUBSTITUTED CYCLOHEXANE DERIVATIVES F. HOFFMANN-LA-ROCHE AG (CH) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272774-A1 Substituted cyclohexane derivatives LSS, CYP51A1, CYP8B1 ALDH1A1 629/4885MAPT 4787/4885HPGD 286/4885
US-20030199550-A1 Substituted cyclohexane derivatives CYP51A1, LSS, CYP46A1 ALDH1A1 498/4885MAPT 4784/4885HPGD 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.